Lifotronic, founded in 2008, is a leading manufacturer of more than 110 premium medical devices both for diagnositc and therapeutic purposes. Headquartered in Shenzhen, China, Lifotronic operates through four factories and thirty sales and service subsidiaries strategically located in China. At Lifotronic, we are committed to our mission by focusing on technology innovation, quality assurance and customer overall satisfaction.
Facts about Lifotronic
1,000 employees
More than 300 R&D engineers
4 factories located in south, east and west of China
Launched China’s first eCLIA system
Products exported to over 60 countries
15,000 hospital users worldwide
1,500 installations in the first tier hospitals in China
Listed on Shanghai Stock Exchange
ISO13485, CE, FDA certified
Lifotronic therapeutic solutions
Wound care: NPWT, ultrasonic debridement, phototherapy
Physiotherapy: Shock wave, Interferential current, Near infrared
DVT prevention: Pneumatic compression therapy
Respiratory care: Airway clearance system, High flow humidification system
Dermatology: Ultraviolet light therapy
Lifotronic In-Vitro diagnostic solutions
eCLIA
HPLC
POCT
Nephelometry (CRP, SAA, ACR)
Company’s Keywords:
npwt, wound care, ivd, hba1c analyzer, specific protein analyzer & urine acr analyzer, electrochemiluminescence, lowlevel laser therapy, pcr test, covid19 antibody
<78
<
<2008